Tech Company Financing Transactions
DVS Sciences Funding Round
On 7/14/2011, DVS Sciences received $14.6 million in Series A funding from 5AM Ventures, Mohr Davidow Ventures and Pfizer Venture Investments.
Transaction Overview
Company Name
Announced On
7/14/2011
Transaction Type
Venture Equity
Amount
$14,600,000
Round
Series A
Investors
Proceeds Purpose
The proceeds will be used to accelerate the company's commercial manufacturing scale-up of its paradigm-shifting multi-parameter single cell analysis solution.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
639 N. Pastoria Ave.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Not Recorded
Overview
DVS Sciences Inc. is an analytical equipment and reagents development company that produces and markets the CyTOF, a high throughput mass cytometer for individual cell analysis based on a novel elemental mass-spectrometry detection technology, and the MAXPAR system of reagents related to massively multi-parametric assays.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Victor
Chief Financial Officer
Mark Tenboer
Chief Technical Officer
Scott Tanner
Co-Founder
Dmitry Bandura
Co-Founder
Vladimir Baranov
Co-Founder
Olga Ornatsky
VP - Operations
Pam Delucchi
VP - Sales
Neil Kennedy
Browse more venture capital transactions:
Prev: 7/14/2011: Telecom Transport Management venture capital transaction
Next: 7/14/2011: Zettics venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs